These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 1303164)

  • 1. Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development--a study of molecular forms.
    Arendt T; Brückner MK; Lange M; Bigl V
    Neurochem Int; 1992 Oct; 21(3):381-96. PubMed ID: 1303164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular forms of acetylcholinesterase and butyrylcholinesterase in human plasma and cerebrospinal fluid.
    Atack JR; Perry EK; Bonham JR; Perry RH
    J Neurochem; 1987 Jun; 48(6):1845-50. PubMed ID: 3572402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system.
    Atack JR; Perry EK; Bonham JR; Candy JM; Perry RH
    J Neurochem; 1986 Jul; 47(1):263-77. PubMed ID: 3711902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
    Wright CI; Geula C; Mesulam MM
    Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain.
    Rakonczay Z
    Acta Biol Hung; 2003; 54(2):183-9. PubMed ID: 14535624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in silico analysis of novel astaxanthin-s-allyl cysteine as an inhibitor of butyrylcholinesterase and various globular forms of acetylcholinesterases.
    Sakayanathan P; Loganathan C; Kandasamy S; Ramanna RV; Poomani K; Thayumanavan P
    Int J Biol Macromol; 2019 Nov; 140():1147-1157. PubMed ID: 31442505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular forms of acetylcholinesterases in Alzheimer's disease.
    Younkin SG; Goodridge B; Katz J; Lockett G; Nafziger D; Usiak MF; Younkin LH
    Fed Proc; 1986 Dec; 45(13):2982-8. PubMed ID: 2430839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular forms of acetylcholinesterase in subcortical areas of normal and Alzheimer disease brain.
    Siek GC; Katz LS; Fishman EB; Korosi TS; Marquis JK
    Biol Psychiatry; 1990 Mar; 27(6):573-80. PubMed ID: 2322617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative development and molecular forms of acetyl- and butyrylcholinesterase during morphogenesis and synaptogenesis of chick brain and retina.
    Layer PG; Alber R; Sporns O
    J Neurochem; 1987 Jul; 49(1):175-82. PubMed ID: 3585328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities and kinetic properties of lumbar cerebrospinal fluid cholinesterases in relation to clinical diagnosis, severity, and progression of Alzheimer's disease.
    Huff FJ; Reiter CT; Protetch J
    Can J Neurol Sci; 1989 Nov; 16(4):406-10. PubMed ID: 2804802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral cholinergic disturbances in Alzheimer's disease.
    Rakonczay Z; Horváth Z; Juhász A; Kálmán J
    Chem Biol Interact; 2005 Dec; 157-158():233-8. PubMed ID: 16243305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's disease.
    Ruberg M; Rieger F; Villageois A; Bonnet AM; Agid Y
    Brain Res; 1986 Jan; 362(1):83-91. PubMed ID: 3942870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential laminar distribution of acetylcholinesterase and butyrylcholinesterase containing tangles in the cerebral cortex of Alzheimer's disease.
    Coleman AE; Geula C; Price BH; Mesulam MM
    Brain Res; 1992 Nov; 596(1-2):340-4. PubMed ID: 1467998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinesterases in normal and Alzheimer's disease primary olfactory gyrus.
    Hamodat H; Cash MK; Fisk JD; Darvesh S
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):571-583. PubMed ID: 28644906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular forms of butyrylcholinesterase in the human neocortex during development and degeneration of the cortical cholinergic system.
    Atack JR; Perry EK; Bonham JR; Candy JM; Perry RH
    J Neurochem; 1987 Jun; 48(6):1687-92. PubMed ID: 3572398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type.
    Appleyard ME; McDonald B
    J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1074-8. PubMed ID: 1469405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems.
    Ruberg M; Villageois A; Bonnet AM; Pillon B; Rieger F; Agid Y
    J Neurol Neurosurg Psychiatry; 1987 May; 50(5):538-43. PubMed ID: 2953866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the beta-amyloid protein precursor of Alzheimer's disease.
    Sberna G; Sáez-Valero J; Li QX; Czech C; Beyreuther K; Masters CL; McLean CA; Small DH
    J Neurochem; 1998 Aug; 71(2):723-31. PubMed ID: 9681463
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.